Finanse publiczne · 02/01/2026
Statutory Updates to Branded Prescription Drug Fee Regulations
The proposed regulations update the annual fee imposed on covered entities manufacturing or importing certain branded prescription drugs, following changes to the Manufacturer Discount Program under the Inflation Reduction Act of 2022.